Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.

Dai, Dongjun; Guo, Yinglu; Shui, Yongjie; Li, Jinfan; Jiang, Biao; Wei, Qichun

Dai, Dongjun; Guo, Yinglu; Shui, Yongjie; Li, Jinfan; Jiang, Biao; Wei, Qichun.

Afiliação

Dai D; Department of Radiation Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Guo Y; Department of Radiation Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Shui Y; Department of Radiation Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li J; Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jiang B; Department of Radiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Wei Q; Department of Radiation Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Front Mol Biosci ; 8: 775562, 2021.

Article em En | MEDLINE | ID: mdl-34970597

Palavras-chave

B cells; PD-L1; The Cancer Genome Atlas; histone deacetylase inhibitor; locally advanced head and neck squamous cell carcinoma; radiosensitivity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Mol Biosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google